JESSICA CARTWRIGHT: Open Payments
NPI 1568080877 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 41 payments from 17 companies in 2025. Trend: 2023 $53 · 2024 $185 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $200 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| UCB, Inc. | 2 | $58 |
| GENZYME CORPORATION | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $34 |
| PFIZER INC. | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Intra-Sana Laboratories | 1 | $28 |
Products named: SKYRIZI, VRAYLAR, DUPIXENT, REXULTI, Bimzelx, Auvelity, Quviviq, Symbravo.
Industry payments across OK — which companies pay providers there.
